Tuesday, August 27, 2019 7:48:16 AM
It will be in the form of Financials.
Over the last 4 months Inspyr Therapeutics has been catching up on the past 2 years of Financials to become current. They are now just 2 Quarters left to become fully reporting. These last 2 10q's can be dropped at any time between now and September 30th, 2019
On May 22nd, 2019 Inspyr Therapeutics released Two 10q's less then a month after 2017's 10K was released April 26th, 2019.
2018's 10K was released on August 6th, 2019
https://www.sec.gov/cgi-bin/browse-edgar?company=INSPYR+THERAPEUTICS&owner=exclude&action=getcompany
https://www.sec.gov/Archives/edgar/data/1421204/000121390019014714/f10k2018_inspyrtherapeutics.htm
Section F-21
** NOTE 15 – SUBSEQUENT EVENTS -
"extended the maturity date of such debentures until September 30, 2019"
Recent RBSH News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 09:19:43 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 08:36:33 PM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM